Navigation and service


National Scientific Advice at the Paul-Ehrlich-Institut (PEI)

Based on the requirements for medicinal products with regard to quality, efficacy, safety, and environmental risk assessment, early interaction with regulatory bodies fosters the translation of research findings into products and product development. Therefore the PEI provides early scientific advice and regulatory guidance to promote efficient translation of basic research findings into new treatment approaches.

Advice meetings for the following medicinal products in the responsibility of the PEI are directly coordinated by the respective units of the PEI:

  • Viral Vaccines
  • Microbiological Vaccines
  • Allergens
  • Monoclonal and Polyclonal Antibodies (except Joint Scientific Advice meetings)
  • Coagulation Products

Innovation Office:

  • provides informal advice on the development of the following medicinal product areas:

    Areas of Advice Areas of AdviceFigure: Products for which Scientific Advice meetings are organized by the Innovation Office. Source: PEI

  • coordinates Kick-Off and Scientific Advice meetings for the project initiatives DKTK and DZIF
  • organizes Joint Scientific Advice meetings (liaising with the Federal Joint Committee (G-BA)), also for mono- and polyclonal antibodies

Innovation Office

Phone: +49 6103 77 2772

Fax +49 6103 77 1234


How do you rate this article

This Page